Open source-based solution delivers industry's highest performance with lower TCO in hybrid cloud environments
SANTA CLARA, June 30, 2020 – IP Infusion, a leading provider of network disaggregation solutions for telecom and data communications operators, today announced the general availability of the Virtual SD-Edge router. The Virtual SD-Edge router may be deployed on x86 servers or public cloud services, and securely extends WAN connectivity into hybrid cloud environments for Enterprises and MSPs.
The Virtual SD-Edge router, the first product available within IP Infusion's Open SD-Edge platform, supports enterprise class networking features such as routing, VPN, firewall, NAT and QoS in a comprehensive package. Virtual SD-Edge provides carrier class routing and enables multiple use cases, including cloud migration, branch to cloud as well as multi-site, multi-cloud connectivity.
Previous users of the popular Brocade Vyatta 5600 solution now have an improved and modern solution that delivers higher performance with even lower TCO.
Virtual SD-Edge is based on DANOS-Vyatta edition (DVe), which is widely deployed across multiple, white box use cases in AT&T's production network as well as other service provider networks. DVe is built on DANOS, the first open source, carrier-targeted network operating system (NOS) project hosted by the Linux Foundation and offers industry-leading control plane features and a more complete data plane integration for switching silicon. DANOS is available on GitHub to facilitate evaluations and Proof of Concepts of disaggregation for VNFs and applications.
"To reduce costs and become more agile, large and small businesses are rapidly migrating to the cloud and require enterprise-class cloud connectivity. Our Virtual SD-Edge is optimized for streamlined packet processing and virtualized resource utilization," said Atsushi Ogata, President and CEO, IP Infusion. "The combination of a compact footprint, ability to drive 10 Gbps+ throughput per Physical Core and advanced control plane enable a broad range of virtual and cloud networking use cases."
IP Infusion's Virtual SD-Edge solution is now available for deployment in the Azure Marketplace and as a VM image for private cloud or x86 based virtual environments and will soon be on Amazon Web Services (AWS).
For more information on Virtual SD-Edge: www.ipinfusion.com/VirtualSD-Edge.
For more information on DANOS Vyatta Edition: /products/danos-vyatta-edition/
For more information on DANOS open source network operating system: https://www.danosproject.org/
IP Infusion 소개
IP Infusion is a leading provider of open network software and solutions for carriers, service providers and data center operators with over 500 customers and thousands of deployments. Our solutions enable network operators to disaggregate their networks to accelerate innovation, streamline operations, and reduce Total Cost of Ownership (TCO). Network OEMs may also disaggregate network devices to expedite time to market, offer comprehensive services, and achieve carrier grade robustness.
IP Infusion is headquartered in Santa Clara, Calif., and is a wholly owned and independently operated subsidiary of ACCESS CO., LTD. Additional information can be found at http://www.IPInfusion.com.
IP Infusion and OcNOS are trademarks or registered trademarks of IP Infusion. ACCESS is a registered trademark or trademark of ACCESS CO., LTD. in the United States, Japan and/or other countries. Northforge Innovations is a registered trademark of Northforge Innovations, Inc. All other trademarks, service marks, registered trademarks, or registered service marks mentioned are the property of their respective owners.
-end-
미디어 문의
Katherine Verducci, 1903 PR, kverducci@1903pr.com, 408.429.5779
IP Infusion 소개
IP Infusion은 오픈 네트워킹 소프트웨어의 선도적 공급업체로서, 서비스 프로바이더, 데이터센터, AI 패브릭 네트워크를 위한 캐리어급 네트워크 운영체제인 OcNOS를 제공합니다. 26+ 년의 네트워킹 전문성과 전 세계 600+ 오퍼레이터 실적을 바탕으로, Edgecore Networks, UfiSpace, Celestica 등 파트너의 검증된 오픈 하드웨어에서 개방적이고 멀티벤더이며 비용 효율적이고 유연한 네트워크 인프라를 구현합니다. IP Infusion은 ACCESS CO., LTD.(도쿄증권거래소: 4813)의 완전 자회사입니다.
미디어 문의
For press inquiries, analyst briefings, or media materials, please 팀에 문의 or email pr@ipinfusion.com.
미래예측 진술
본 보도자료에는 IP Infusion의 제품, 기술 및 계획에 관한 미래예측 진술이 포함될 수 있습니다. 미래예측 진술은 공개일 현재 이용 가능한 정보에 기초하며 위험과 불확실성을 수반합니다. 실제 결과는 다를 수 있습니다. 제품 계획, 기능, 출시 시기 및 제공 여부는 예고 없이 변경될 수 있으며 약정, 약속 또는 법적 의무를 구성하지 않습니다. IP Infusion은 미래예측 진술을 갱신할 의무를 지지 않습니다.